Key facts
- Risa Labs’s last known valuation is $42.0M (Jan 2026).
- It has raised $14.6M; the latest was Early Stage VC ($11.1M) in Jan 2026.
- Notable investors include General Catalyst, Optum Ventures, Binny Bansal, z21 Ventures, Ashish Gupta — 10 tracked in total.
- Status: Privately Held (backing).
Leadership
- Rishabh SahuFounder
- Kshitij JaggiChief Executive Officer & Founder
- Kumar ShivangChief Technology Officer & Founder
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Risa Labs
- ·The full record, as it builds
Funding rounds
No funding rounds for Risa Labs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Risa Labs
Developer of a AI-driven multi-agent system architecture platform designed to establish medical necessity for prior authorization workflows. The company offers a system combining RPA, rules engines, generative AI, EHR data analysis, and human expert review, enabling medical companies to automate authorization processes, apply payer-specific rules, and reduce documentation gaps and denials.
- Sector
- Information Technology
- HQ
- Palo Alto, CA, United States
- Founded
- 2024
- Employees
- 48
- Website
- risalabs.ai/
- Ownership
- Privately Held (backing)
Risa Labs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Risa Labs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Risa Labs in its N-PORT filings yet. We sweep new filings monthly.